Ticker brief
LABT LAKEWOOD-AMEDEX BIOTHERAPEUT
Consumer, Non-cyclical · Biotechnology
last close
$2.30
1 day
-7.6%
14 days
+1.3%
mkt cap
·
signals 14d
6
authors 14d
3
crowd 14d
+2.2σ
Sentiment — last 14 days
daily mean sentiment, 2026-08-26 → 2026-08-27 · now +0.58 (−1 bearish … +1 bullish)
Who spoke3
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @joealertz | C | -2.72 | 3 | +0.58 |
| @frankyboyz | C | -2.26 | 2 | +0.42 |
| @BawzRs | C | +1.61 | 1 | +0.70 |
Recent signals6of 6 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-27 | @joealertz | +0.65 | Expects strong upside if LABT breaks above $3. | -7.6% | tweet ↗ |
| 2026-08-27 | @joealertz | +0.70 | Started a LABT position here. — Explicitly reports taking a starter position. | -7.6% | tweet ↗ |
| 2026-08-27 | @joealertz | +0.40 | Adds LABT to a premarket watch list after buying interest and says it is primed for a large move. | -7.6% | tweet ↗ |
| 2026-08-26 | @BawzRs | +0.70 | LABT could rip on high borrow cost and its small float. — Bullishly calls for a LABT squeeze, citing 680% borrow cost and a 1M float. | -6.1% | tweet ↗ |
| 2026-08-26 | @frankyboyz | +0.35 | LABT short availability falls from 15,000 shares to 2,500. | -6.1% | tweet ↗ |
| 2026-08-26 | @frankyboyz | +0.50 | LABT is a high-watch squeeze candidate based on volume, scarce borrow and 678% cost to borrow. | -6.1% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.